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Abstract
Absence of a-crystallins (aA and aB) in retinal pigment epithelial (RPE) cells renders them susceptible to oxidant-induced cell
death. We tested the hypothesis that the protective effect of a-crystallin is mediated by changes in cellular glutathione
(GSH) and elucidated the mechanism of GSH efflux. In a-crystallin overexpressing cells resistant to cell death, cellular GSH
was .2 fold higher than vector control cells and this increase was seen particularly in mitochondria. The high GSH levels
associated with a-crystallin overexpression were due to increased GSH biosynthesis. On the other hand, cellular GSH was
decreased by 50% in murine retina lacking aAo raB crystallin. Multiple multidrug resistance protein (MRP) family isoforms
were expressed in RPE, among which MRP1 was the most abundant. MRP1 was localized to the plasma membrane and
inhibition of MRP1 markedly decreased GSH efflux. MRP1-suppressed cells were resistant to cell death and contained
elevated intracellular GSH and GSSG. Increased GSH in MRP1-supressed cells resulted from a higher conversion of GSSG to
GSH by glutathione reductase. In contrast, GSH efflux was significantly higher in MRP1 overexpressing RPE cells which also
contained lower levels of cellular GSH and GSSG. Oxidative stress further increased GSH efflux with a decrease in cellular
GSH and rendered cells apoptosis-prone. In conclusion, our data reveal for the first time that 1) MRP1 mediates GSH and
GSSG efflux in RPE cells; 2) MRP1 inhibition renders RPE cells resistant to oxidative stress-induced cell death while MRP1
overexpression makes them susceptible and 3) the antiapoptotic function of a-crystallin in oxidatively stressed cells is
mediated in part by GSH and MRP1. Our findings suggest that MRP1 and a crystallin are potential therapeutic targets in
pathological retinal degenerative disorders linked to oxidative stress.
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Introduction
Oxidative stress is a contributing factor to retinal pigment
epithelial (RPE) cell dysfunction in age-related macular degener-
ation (AMD) [1,2]. Characteristic features of early AMD include
the accumulation of subretinal deposits between RPE and Bruch’s
membrane and RPE morphologic changes [1,3]. Dysregulated
growth factor expression, scavenger receptors, and the mTOR
pathway have all been implicated in mediating or modulating
these pathologic changes [4–8].
Redox of RPE also plays a critical role in combating oxidative
stress [1]. Among the cellular antioxidant constituents, reduced
glutathione (GSH) is the major non-protein thiol antioxidant
with pluripotent functions [9,10]. Even though GSH is synthesized
in the cytosol, it is distributed in intracellular organelles such
as endoplasmic reticulum, nucleus and mitochondria. GSH
depletion has been attributed to apoptosis either by predisposing
cells to apoptosis or by modulating mitochondrial membrane
potential and subsequent activation of caspases [11]. Since
mitochondrial GSH (mGSH) plays a significant role in cellular
defense against pro-oxidants, depletion of mGSH poses a threat to
cell viability.
Elucidating GSH transport mechanisms of different cellular
compartments has received considerable recent attention. In the
brain, release of GSH from astrocytes is an important component
of GSH homeostasis [12]. Brain astrocytes maintain redox balance
by the ATP-dependent extrusion of GSH by ATP-binding cassette
transporter, multidrug resistance protein 1 (MRP1) [12]. Studies
have demonstrated that both glutathione disulfide (GSSG) and
GSH are substrates for MRP1 [12–15]. However, information on
expression and regulation of proteins associated with GSH efflux
in the retina is scarce [16]. Differences in mRNA expression of
MRPs in different RPE cell lines was reported [17]. However, the
role of efflux transporters, particularly MRP1 in GSH regulation
in RPE cells under unstressed and stressed conditions has not been
studied so far.
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including the retina [18]. aA and aB crystallin both serve a cell
protection function and a chaperone function. In lens epithelial
cells, a-crystallins are anti-apoptotic against UVA-irradiation and
tumor necrosis factor-a stimulation [18,19]. a-Crystallins also
function as chaperones by preventing aggregation and pathologic
protein misfolding [20]. Overexpression of either human HSP27
or aB crystallin resulted in increased total GSH levels and
decreased basal levels of intracellular reactive oxygen species
(ROS) [21,22].
Our laboratory has investigated the role of a-crystallins in RPE
cell physiology and their regulation by oxidative stress [23]. Lack
of a-crystallins rendered RPE cells more susceptible to apoptosis
caused by oxidative stress [23]. Overexpression of aAo raB
crystallin had similar degrees of protection in lenticular as well
as non-lenticular cells [24]. We showed that RPE cells lacking
either aAo raB crystallin are equally susceptible to H2O2-
induced oxidant insult [23]. Recently, we discovered that aB
crystallin is secreted from RPE cells in exosomes, and exogenous
aB crystallin protected RPE cells from oxidative stress-induced
apoptosis [25].
The link between the protective function of a-crystallin and
cellular antioxidant status is not well understood. Both GSH and
redoxins are major factors with critical redox functions in RPE
cells [26]. GSH levels are elevated in a-crystallin overexpressing
human lens epithelial cells [27]. However, the nature and
mechanism of GSH participation in the a-crystallin-mediated
antiapoptotic function of RPE cells has not been studied. Here, we
investigated the relationship between GSH, redoxins and the
antiapoptotic function of a- crystallins in RPE. For the first time,
we provide evidence that MRP1 plays a key role in maintaining
cellular thiol homeostasis by regulating GSH efflux in RPE.
Results
a-crystallin overexpressing RPE cells are resistant to
oxidative stress induced cell death
We generated a-crystallin overexpressing stable cell lines (Fig. 1
A–D) and demonstrated that aA crystallin or aB crystallin
overexpressing cells were more resistant to H2O2-induced cell
death than vector control cells (Fig. 1E). Overexpression of aA
crystallin or aB crystallin resulted in 10% cell death at
concentrations of H2O2 that caused 30% cell death in control
cells (Fig. 1E, F). Further, caspase 3 activation was inhibited in a-
crystallin overexpressing cells exposed to H2O2 (Fig. 1G). The
dose and duration of H2O2 used in these studies were 150 mM and
24 h, respectively, as has been validated in our previous work [23].
Higher thiol levels provide protection from oxidative
stress in a-crystallin overexpressing cells
We next investigated the link between a-crystallin expression,
intracellular thiol levels and enhanced cell survival in oxidative
stress. Our data revealed a significant (P,0.05) 2-fold increase in
cellular GSH levels in a-crystallin overexpressing clones when
compared to controls (Fig. 2A). One of the main mechanisms for
elevation of cellular GSH is increased biosynthesis catalyzed by the
rate-limiting enzyme glutamate-cysteine ligase (GCL) [27]. The
increase in total GSH levels was associated with significant
upregulation of the gene and protein expression of the catalytic
unit of GCL (GCLC) but not GCLM, the modifier unit of GCL
(Fig. 2B–D). Mitochondrial fractions from a-crystallin overex-
pressing cells had significantly higher GSH levels (P,0.01 vs
vector control) after treatment with 150 mMH 2O2 for 24 h
(Fig. 2E, F). The magnitude of increase in GSH level in cytosol,
although higher than controls, was less than that of the
mitochondrial fraction. Overall, these results suggest the signifi-
cance of GSH and its biosynthetic enzymes in protection against
oxidant stress in ARPE-19 cells overexpressing a-crystallins.
Thiol status of the retina is compromised in a-crystallin
KO retina
Retinas from a-crystallin KO mice are highly susceptible to
cobalt chloride-induced oxidative stress [28]. We studied the
changes in thiol status in mouse retina lacking aA-or aB
crystallin. Total GSH levels in the neural retina and choroid/
RPE complex of the a-crystallin KO and WT controls were
determined. Under unstressed conditions, GSH levels were about
50% lower (P,0.01 vs age-matched WT) in aA crystallin and aB
crystallin KO RPE/choroid complex while corresponding neural
retina showed a 30% and 50% decrease in GSH, respectively
(Fig. 3A). No significant changes in the levels of the catalytic or
modifier subunits of GCL in aA and aB crystallin KO mice were
found either at the mRNA (Fig. 3B, C) or the protein level (Fig. 3D)
of samples from the posterior eye cups (neural retina, RPE and
choroid). Additionally, we determined the effect of a-crystallin KO
on the expression of thioredoxins (Trx) and glutaredoxins (Grx) in
the retina and in the RPE cells [26]. Trx1, Trx2, Grx1 and Grx2
mRNAs were significantly (P,0.01) downregulated in a-crystallin
KO retina (Fig. S1A). Similarly, Trx1, Trx2, and Grx1 protein
levels were also downregulated in aA crystallin KO retina
(Fig. S1B).
GSH efflux in a-crystallin KO and a-crystallin
overexpressing cells
A major determinant of intracellular GSH levels is GSH efflux
[29]. GSH efflux was significantly (P,0.01) higher in a-crystallin
overexpressing cells when compared to vector control cells
(Fig. 4A). Exposure to H2O2 did not further increase the amount
of GSH released from a-crystallin overexpressing cells; however,
GSH release was significantly (P,0.05) increased in H2O2-treated
vector control cells (Fig. 4A). A significant upregulation of GCLC
was observed in the a-crystallin overexpressing cells with H2O2
with no apparent change of the GCLM (Fig. 4B, C). On the other
hand, in aB crystallin KO RPE cells, unstimulated GSH efflux
amounted to 9 mmol/ml in 5 h which was significantly (P,0.05)
higher than the 5 mmol/ml in 5 h in WT RPE cells (Fig. 4D). A
significant increase in GSH release was found when WT RPE cells
were challenged with 150 mMH 2O2 for 5 h (Fig. 4D). This
increase in GSH release could be attributed to an increase in GSH
biosynthesis since GCLC levels were significantly higher (Fig. 4E)
in RPE isolated from aB crystallin KO mice. However, no further
increase in GSH efflux was seen in aB crystallin KO RPE exposed
to the same concentration of H2O2 (Fig. 4F).
MRP-related GSH transporters in RPE cells
We then proceeded to characterize the transporter(s) mediating
GSH (and GSSG) efflux from RPE cells. Several MRPs are known
to mediate GSH efflux in mammalian cells [9,30]. To determine
the presence of MRPs in RPE, MRP mRNA levels were analyzed
by RT-PCR. RNA isolated from RPE cells was amplified using
specific MRP primer sequences (Table S1). mRNAs encoding
for MRP1, MRP2, MRP3, MRP4, MRP5, MRP6, and MRP7
were detected in RPE cells (Fig. S2A). MRP1 was the most
abundant of the MRP family members in RPE (Fig. S2B). All
further experiments were performed with MRP1 because it is the
most well characterized MRP with respect to efflux of GSH and
GSSG [30].
MRP1-Mediated GSH Efflux in RPE Cells
PLoS ONE | www.plosone.org 2 March 2012 | Volume 7 | Issue 3 | e33420Localization of MRP1 in a-Crystallin overexpressing RPE
cells
In subconfluent ARPE cells, MRP1 is predominantly localized
in the plasma membrane and the staining pattern is punctate
(Fig. 5A). In human polarized RPE monolayers, we observed
lateral membrane localization of MRP1 (Fig. 5B). Biotinylation
of intact cells with subsequent immunoblot analysis revealed
surface localization of MRP1 in the membrane fraction (Fig. 5C).
These studies further established that membrane expression of
MRP1 was almost three fold higher (P,0.01) in aB crystallin
overexpressing cells than vector control cells (Fig. 5C) which
correlated well with the increased GSH efflux in a-crystallin
overexpressing cells (cf Fig. 4A). In addition, cellular MRP1
expression showed a .2.5 fold increase in aB crystallin
overexpressing cells (Fig. 5D) as compared to vector control cells.
Furthermore, consistent with GSH efflux under oxidative stress
(300 mMH 2O2 for 36 h), we observed a .2 fold increase in
MRP1 expression only in vector control cells subjected to
oxidative stress.
Having established that increased a-crystallin levels increased
MRP1 expression, we then investigated whether knocking down of
aB crystallin could affect the expression of MRP1. As seen in
Fig. 5E, a significant (P,0.001) suppression of aB crystallin was
achieved by siRNA silencing. MRP1 expression tended to increase
in aB crystallin knock-down RPE cells and treatment with H2O2
(200 mM for 24 h) further increased MRP1 expression by 1.5 fold
(Fig. 5F). These studies suggest that MRP1 regulates GSH efflux
under conditions of oxidative stress in RPE cells.
Effect of MRP1 inhibition on GSH release and cell death
To further confirm that MRP1 is involved in GSH efflux in RPE
cells, we inhibited MRP1 by pharmacological agents and siRNA-
mediated gene silencing. When serum-starved RPEcellswere treated
with MRP inhibitors (75 mM-MK571 or 5 mM-sulfinpyrazone) for
5h ,as i g n i f i c a n t5 0 %( P ,0.01) decrease in GSH efflux was observed
(Fig. 6A). MK571 and sulfinpyrazone are non-specific MRP
inhibitors and can therefore be expected to inhibit some or all the
MRP isoforms present in RPE cells (Fig. S2A).
Figure 1. aA and aB crystallin protect RPE cells from H2O2-induced oxidative stress. aA and aB crystallin expression in two stably
overexpressing ARPE-19 cell lines (aA1
+, aA2
+, aB1
+, aB2
+) was significantly higher than empty vector controls (A–D). Immunoblot analysis of ARPE-19
cells expressing aA crystallin and aB crystallin (A,C). Protein samples (25–75 mg) were separated by 15% Tris-HCL gel, transferred to PVDF membrane,
and subsequently reacted with rabbit aA crystallin and aB crystallin antibodies. Protein expression quantified by densitometry is shown as ratio
normalized with GAPDH (B, D). Cell death induced by H2O2 was significantly reduced in a-crystallin overexpressing ARPE-19 cells (E). a-Crystallin
overexpressing cells were incubated with 150 mMH 2O2 for 24 h in serum free medium and cell death was analyzed by TUNEL staining and semi-
quantification of TUNEL positive cells are presented as percentage of dead cells in F. Blue: DAPI nuclear staining; Red: TUNEL positive cells. Caspase3
activation with H2O2 in a-crystallin overexpressing cells (G). Twenty four hours after treatment, cell lysates (60 mg total protein) were run in
inmmunoblots for active caspase 3 and then reprobed for GAPDH as a loading control. aA
+ -aA crystallin overexpressing clones, aB
+ -aB crystallin
overexpressing clones, aA- aA crystallin, aB- aB crystallin. ** P,0.01 H2O2 vs aA
+ and aB
+.*P ,0.05 Vector vs a-crystallin clones.
doi:10.1371/journal.pone.0033420.g001
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selectively suppressed its expression by RNA interference. ARPE-
19 cells were transfected with MRP1-specific siRNA duplexes and
after 48 h, mRNA and protein levels of MRP1 were reduced by
approximately 65% (Fig. 6B) and 70–80% (Fig. 6C), respectively.
MRP1 silencing caused a significant 60% reduction (P,0.01 vs
scrambled control) in GSH efflux from unstressed cells in 5 h
(Fig. 6D). No further change in GSH efflux was observed in
oxidatively stressed cells after incubation with 150 mMH 2O2 for
5 h (Fig. 6D). Incubation of RPE cultures with MRP1 inhibitors or
by MRP1 siRNA at the indicated doses and duration did not affect
cell viability (Fig. 6E).
MRP1 down regulated cells were resistant to H2O2-induced
(150 mM for 24 h) cell death (Fig. 7A). Cellular GSH levels in the
scrambled siRNA and MRP1 siRNA groups were 16.9960.45
and 23.1160.20 nmol/mg cellular protein, respectively. However,
there was a significant decrease (P,0.05) in GSH levels in control
cells treated with H2O2 and no further change of GSH levels in
MRP1 silenced cells (Fig. 7B). Cellular GSSG levels increased
significantly (P,0.05) in control cells treated with H2O2 (Fig. 7C).
In MRP1 silenced cells, the basal level of GSSG was higher than
control cells and when incubated with H2O2, a 6.8 fold increase in
GSSG levels was observed over scrambled controls (Fig. 7C). GSH
efflux decreased by a significant 60% in MRP1 silenced cells with
no further change with H2O2 treatment (Fig. 7D). The
corresponding efflux for GSSG in MRP1 silenced cells was
negligible and was below the detection limit of the assay (data not
shown). Exposure of siRNA-MRP1 treated cells to H2O2 for 24 h
led to a significant decrease in active caspase 3 levels when
compared with corresponding control cells treated with H2O2
(Fig. 7E). Reduced cell death in MRP1 silenced cells treated with
H2O2 under conditions of higher cellular GSSG may in part be
Figure 2. Intracellular GSH levels in a-crystallin overexpressing cells. Cellular GSH levels in ARPE-19 cells stably overexpressing aA crystallin
and aB crystallin increased significantly (P,0.05) when compared to vector only cells (A). Relative expression of the mRNA levels of the catalytic unit
(GCLC) and modifier unit (GCLM) of GSH biosynthetic enzyme GCL (B, C). A significant increase in GCLC was found for mRNA and protein while no
significant change was observed either at the gene or protein levels for the modifier unit (B–D). Protein bands were quantified and presented as ratio
normalized to loading control, GAPDH. Panels E and F show GSH levels in the cytosol and mitochondrial fractions from vector control and a-crystallin
overexpressing ARPE-19 cells challenged with 150 mMH 2O2 for 24 h. While the magnitude of increase in the cytosolic pool is relatively smaller, a
significant (P,0.01) increase in mitochondrial pool of GSH was observed in a-crystallin overexpressing cells. Data are normalized to control taken as
100%. *P,0.05 vs controls; ** P,0.01 vs controls.
doi:10.1371/journal.pone.0033420.g002
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conversion of GSSG to GSH (Fig. 7F–H). Overall, these data
support the conclusion that inhibition of MRP1 protects RPE cells
from H2O2-induced cell death which is mediated by changes in
thiol status and GR.
Increased GSH efflux and susceptibility to cell death in
MRP1 overexpressing cells
We next overexpressed human MRP1 in ARPE-19 cells to
study whether MRP1 overexpression would affect GSH and
GSSG release. Real-time PCR and immunoblot analyses estab-
lished the level of overexpression (Fig. 8A, B) in MRP1 transfected
cells. GSH release was significantly (P,0.01) higher in MRP1
overexpressing than vector controls treated with H2O2 for 5 h
(Fig. 8C). There was no significant change in LDH release in
MRP1 overexpressing cells when compared with control cells
indicating that GSH release was not due to toxicity (Fig. 8D).
Intracellular GSH levels in MRP1 overexpressing cells
(6.262.4 nmol/mg protein) were significantly (P,0.05) lower
than vector control cells (9.961.7 nmol/mg protein).
We further examined the effect of H2O2 (150 mM) exposure for
5 h, 24 h, and 36 h in control and MRP1 overexpressing cells.
The extent of cell death did not differ between control and MRP1
overexpressing cells at a shorter duration (5 h) of H2O2 treatment
(Fig. 8D). However, at 24 h and 36 h of H2O2 treatment, a
progressive increase in cell death was seen in control cells.
Oxidant-induced cell toxicity in MRP1 overexpressing cells
was significantly higher (P,0.05) than that seen in vector
alone control cells (Fig. 8D). This finding was corroborated
by levels of caspase 3 activation which progressively increased
as the duration of H2O2 exposure increased (Fig. 8E). To explore
the mechanism of cell death, we determined the GSH and
GSSG levels in MRP1 overexpressed cells treated with H2O2 for
36 h. Cellular GSH levels were reduced by 32% in MRP1
overexpressed cells compared to vector control cells (Fig. 8F).
H2O2 treatment further significantly (P,0.01) decreased cellular
GSH levels by 25% and 62%, respectively in vector control cells
and MRP1 overexpressed cells (Fig. 8F). However, GSSG levels
were markedly lower in MRP1
+ stressed as well as unstressed cells
when compared to vector alone cells (Fig. 8G). With regard to
efflux, MRP1 overexpressed cells effluxed significantly higher
amounts of GSH vs vector controls with or without exposure to
H2O2 (Fig. 8C, H). On the other hand, GSSG release was very
low in MRP1 overexpressed cells under stressed as well as
unstressed conditions (data not shown). These data show that
MRP1 overexpression enhances RPE susceptibility to oxidant
Figure 3. Cellular GSH levels in the aA and aB crystallin knockout (KO) mouse retina. (A) GSH levels in two tissue segments of the eye,
namely RPE/Choroid and neural retina. Data, presented as percentage over control age-matched mice, showed a significant 50% decrease in GSH
level in the neural retina and a ,25–30% decrease in the RPE/choroid in aA crystallin KO (aA 2/2) and aB crystallin KO (aB 2/2) samples. RNA and
protein were extracted from the posterior eye cup of the crystallin KO and WT mice. The gene expression of the catalytic (B) and the modifier unit (C)
as well as the protein expression (D) of the GSH rate limiting enzyme GCLC did not show any significant change among aA( 2/2), aB(2/2) and WT
mice. GCLC- glutamate-cysteine ligase, catalytic subunit, GCLM- glutamate-cysteine ligase, modifier subunit, KO- knock out, WT- wild type. ** P,0.01
vs controls.
doi:10.1371/journal.pone.0033420.g003
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efflux.
Discussion
RPE cells and retina from a-crystallin KO mice are highly
susceptible to oxidant injury [23,28]. Though multiple molecular
mechanisms have been proposed to account for the function of
crystallins in apoptosis [18], the role of GSH or thiols in this
process has not received much attention. Depending on the
severity of oxidant injury, cells undergo either GSH-dependent
apoptosis or GSH-independent necrosis [31]. We have demon-
strated that H2O2-induced cell death in a-crystallin KO RPE cells
was due to apoptosis [23]. The dose of H2O2 used in the current
study was previously shown by us to induce ROS production in
RPE cells [32]. Here we show that apoptosis induced by H2O2
decreased significantly from about 30% in the control to 10% in
the a-crystallin overexpressing cells. The protection was positively
correlated with intracellular GSH and with mitochondrial GSH,
supporting the notion that the modulation of ROS production was
GSH-dependent in RPE cells. This is also consistent with earlier
observations that small heat shock proteins were unable to protect
against the oxidative insult generated by agents that interfere with
GSH synthesis [22].
Mitochondrial GSH of RPE cells increased 2 fold with H2O2
treatment and by an increase in the cytosolic GSH. The increased
cytosolic GSH triggers enhanced transport of GSH into mitochon-
dria by activating specialized transport mechanisms [33]. In support
of this finding, it has been demonstrated that in neuronal cells,
hydrogen sulfide increases mitochondrial GSH [34]. Because
apoptosis is closely linked to mitochondrial function, it can be argued
that the H2O2-induced increase in mitochondrial GSH, rather than
in cytosolic GSH in a-crystallin overexpressing cells may greatly
contribute to cell protection. Retinal tissue fractions from a-crystallin
Figure 4. GSH export from H2O2-treated a-crystallin overexpressing and aB crystallin KO RPE cells. aA crystallin and aB crystallin
overexpressing cells were treated with 150 mMH 2O2 for 5 h in serum-free medium and extracellular accumulation of GSH was measured. Vector only
cells treated in the same fashion served as controls (A). A significant (P,0.01 vs control) gene upregulation of GCLC (B) was observed while no
significant change occurred in GCLM (C). GSH efflux in non-stressed RPE cells isolated from aB crystallin KO mice showed a significant increase when
compared to RPE cells isolated from WT mice (D). However, oxidative stress (150 mMH 2O2 for 5 h) resulted in a significant (P,0.01) increase in GSH
efflux only in the WT RPE and no further significant increase in efflux was observed in RPE from aB crystallin KO mice. H2O2-induced stress produced a
significant upregulation of the GCLC (E) while GCLM did not show any significant change (F). GCLC- glutamate-cysteine ligase, catalytic subunit,
GCLM- glutamate-cysteine ligase, modifier subunit, WT- wild type. *P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0033420.g004
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between GSH and a-crystallins in neuroprotection.
One of the mechanisms whereby cells maintain their redox
status is by maintaining the GSH/GSSG ratio. The transporters
involved in GSH release remain largely unknown, however, some
studies describe involvement of MRPs in the transport of GSH
and GSSG [15,30,35,36], MRP1 is expressed in all mammalian
cell types and is well characterized [9,37]. Our data demonstrate
that MRP1 is an effective transporter of GSH/GSSG in RPE cells.
Cells treated with inhibitors of MRP decreased GSH release by
about 50–70%. Similar findings have been reported in brain
astrocytes that 60% of the GSH export is carried out by MRP1
[12]. In addition, selective knocking down of MRP1 caused a
decrease in GSH release in unstressed and stressed conditions,
providing direct evidence for the involvement of MRP1 in GSH-
related cellular protection. We could not detect extracellular
GSSG in MRP1 silenced RPE cells, a finding similar to that in
astrocytes cultured from MRP1 KO mice [12]. Together, these
data establish MRP1 as the major transporter of GSH and GSSG
release in RPE.
Figure 5. MRP1 is localized to the plasma membrane in human RPE cells. ARPE-19 cells (A) and polarized RPE monolayer from fetal human
RPE cells (B) were fixed and incubated with a monoclonal antibody against MRP1 followed by a fluorescence labeled anti-mouse secondary antibody.
Images were taken on a confocal laser-scanning microscope. (C) Vector control and aB crystallin overexpressing cells were labeled with biotin and
surface labeled protein samples were analyzed by immunoblot for MRP1. A significant almost 3 fold increase in MRP1 protein expression was found.
(D) MRP1 protein expression in vector control and aB crystallin overexpressing cells with and without oxidative stress. Cells were incubated with
300 mMH 2O2 for 36 h in serum-free medium and total cell lysate was subjected to immunoblot analysis for MRP1 protein. Expression of MRP1 protein
was .2 fold in aB crystallin overexpressing cells as compared to vector control cells. Treatment with H2O2 did not significantly alter MRP1 expression
in aB crystallin overexpressing cells, however, a significant .2-fold increase was observed in vector control cells exposed to H2O2. (E) ARPE-19 cells
were transiently transfected with scrambled and aB crystallin siRNA (50 nM) and protein was harvested 72 h post transfection. Whole cell lysates
(20 mg of total protein) were subjected to immunoblot analysis using a rabbit polyclonal antibody against aB crystallin. aB crystallin protein
expression was markedly reduced by .80% in siRNA transfected cells 72 h post-transfection. (F) MRP1 expression in aB crystallin-silenced cells with
and without oxidative stress with H2O2. Transfected cells were treated with 200 mMH 2O2 for 24 h in serum free medium and total protein (100 mg)
was subjected to immunoblot analysis. While there is no apparent change in MRP1 protein expression in aB crystallin-silenced cells, H2O2 increased
MRP1 expression 1.5 fold in aB crystallin-silenced cells. GAPDH was used as a loading control for all immunoblot analyses. GAPDH- Glyceraldehyde 3-
phosphate dehydrogenase, MRP1- Multidrug resistance protein 1, aB
+- aB crystallin. Scr. -Scrambled.
doi:10.1371/journal.pone.0033420.g005
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membrane of non-polarized and polarized human RPE cells.
MRP1 is localized to the basolateral membrane of epithelial cells
in most tissues [38,39]. Plasma membrane localization of MRP1 is
critical for GSH transport. For example, it has been demonstrated
that MRP1 is involved in GSH efflux in Jurkat cells where it is
localized in the plasma membrane. In contrast, Raji cells lacked
MRP1 at the plasma membrane and were unable to export GSH
[35]. Levels of MRP1 were reported to increase after exposure to
oxidative stress inducing agents [40]. We provide evidence that
expression of MRP1 can be induced in cultured RPE treated with
H2O2. Thus, the present study suggests that regulation of MRP1
in RPE cells under conditions of oxidative stress is redox sensitive
and could help to maintain cellular homeostasis.
Intracellular GSH regulates the ability of cells to undergo
apoptosis. Thus, experimentally increasing intracellular GSH
decreases apoptosis while cells with lower GSH are more
susceptible to apoptotic stimuli [41]. Intracellular GSH levels are
regulated by three major ways during oxidant injury [42]: by
inducing enzymatic synthesis of GSH via upregulation of GCLC,
by the action of GR, which rapidly converts GSSG to GSH using
NADPH as a substrate, and by cellular transport of GSH [42].
Our data indicate that the extracellular GSH transport mediated
by MRP1 in response to oxidative injury may predispose RPE cells
to caspase-mediated apoptosis given the known role of MRP1 in
GSH and GSSG release [15]. Our study shows that GSSG levels
were also increased in MRP1 silenced RPE cells and oxidative
injury further increased GSSG by 4 fold. However, MRP1
silencing allows RPE cells to maintain their intracellular redox
potential by upregulating GR activity which rapidly converts the
toxic GSSG to GSH and may enhance cell survival. Similar
findings were reported in human aortic endothelial cells where
MRP1 inhibition prevented the decline in intracellular GSH, and
reduced apoptosis caused by oscillatory shear by increasing GR
activity [43]. Inhibition of MRP1 increased cellular GSH levels
and reduced intracellular ROS and prevented angiotensin-induced
apoptosis in endothelial progenitor cells [44]. In addition, in vivo
studies show that the rate of apoptosis was significantly reduced in
MRP1 KO mice and improved re-endothelialization after carotid
artery injury [44]. Thus, multiple mechanisms may be operative in
MRP1-inhibited cells that are more resistant to apoptosis.
On the other hand, we found that MRP1 overexpressing RPE
cells release more GSH under unstressed and stressed conditions,
further confirming the role of MRP1 as an effective GSH
transporter [36,45]. Because of the increased GSH release, steady
state intracellular GSH levels are significantly lower in MRP1
Figure 6. Inhibition of MRP1 significantly decreases basal and apoptotic GSH efflux. GSH efflux in ARPE-19 cells incubated with two MRP1
inhibitors (75 mM MK571 and 5 mM sulfinpyrazone [SP]) for 5 h (A). ARPE-19 cells were transfected with MRP1 siRNA at the indicated concentrations.
RNA and protein were extracted 48 h post transfection. MRP1 mRNA and protein expression was significantly (P,0.01 vs scrambled control)
decreased when compared to control or scrambled siRNA alone (B,C). GSH release from MRP1-silenced ARPE-19 cells incubated with 150 mMH 2O2 for
5 h in serum free medium. A significant decrease (P,0.001 vs scrambled control) in GSH release was observed in 5 h. A decrease in GSH release only
in control cells with no additional change in MRP1 inhibited cells was found and H2O2 treatment did not cause any further change (D). LDH release
measured in MRP1 inhibited cells was not affected by any treatment (E). Values are mean6 SE (n=3–4). LDH- Lactate dehydrogenase. ** Significantly
different from control cells, P,0.01.
doi:10.1371/journal.pone.0033420.g006
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under milder conditions of oxidative stress (5 h exposure to
150 mMH 2O2) RPE cells remain viable and GSH release in
MRP1 overexpressing cells was increased without affecting
intracellular GSH levels, presumably because GSH biosynthesis
was stimulated by a feedback mechanism [36]. However,
prolonged treatment with H2O2 (36 h exposure to 150 mM
H2O2) significantly increased the percentage of apoptotic cells
and caspase activation in MRP1 overexpressing cells compared to
control cells. It is well known that treatment with peroxides
depletes GSH levels in RPE cells [47] leading to apoptosis. Thus,
enhanced GSH release and depletion of intracellular GSH are
important for the progression of apoptosis, and this phenomenon
is applicable to MRP1 overexpressing cells with prolonged H2O2
exposure where the levels of cellular GSH is reduced by 62% and
efflux increased by 1.8 fold. In support, similar results were
reported in V79 Chinese hamster cells overexpressing MRP1
which did not show increased resistance to multiple stressors [45].
Similarly, treatment of MRP1 overexpressing BHK-21 cells with
either verapamil or its derivative rapidly depleted intracellular
GSH content with a strong decrease occurring during the first
hour of treatment, followed by apoptosis [46]. The overexpression
of MRP1 in HeLa cells while contributing to cell death by
oxidative stress through enhanced GSH efflux also prevents
intracellular GSSG accumulation [43,48]. Thus the cell death
observed in MRP1 overexpressing cells can be attributed to
accumulation of ROS from GSH depletion [48]. However, in
another study intracellular GSH levels were not depleted in
MRP1-overexpressing HEK293 cells treated with staurosporine/
Fas antibody despite increased GSH release [36]. These
discrepant findings may be explained by differences in the
duration of stress, different stressors tested, levels of MRP1
overexpression, and difference in cell lines or variable GSH levels
maintained during experimentation among various studies.
While our studies address mainly the regulation and function of
GSH as a MRP1 substrate, the patho-physiological significance of
GSSG which is also transported by MRP1 cannot be overlooked
given its cytotoxicity [14]. With this in mind, we also determined
Figure 7. MRP1-inhibited RPE cells are resistant to cell death. MRP1 silenced and control cells were incubated with 150 mMH 2O2 for 24 h in
serum-free medium. 24 h LDH release was quantified in a 96 well plate reader. LDH release was significantly reduced in MRP1 silenced cells
challenged with H2O2 when compared to similarly treated scrambled transfected cells (A). Cellular GSH (B) and GSSG (C) levels were significantly
higher in MRP1 silenced cells when compared to scrambled controls. GSH efflux was inhibited by 60% in MRP1 silenced cells and did not change
further with oxidant injury (D). Caspase activation, determined by immunoblot of active caspase 3 was reduced in MRP1-silenced cells challenged
with H2O2 when compared to scrambled control cells (E). Glutathione reductase (GR) was significantly upregulated at the mRNA (F) and protein levels
(G) in MRP1 silenced cells exposed to H2O2. Densitometric values are presented as ratio normalized to control (H). * P,0.05, ** P,0.01.
doi:10.1371/journal.pone.0033420.g007
MRP1-Mediated GSH Efflux in RPE Cells
PLoS ONE | www.plosone.org 9 March 2012 | Volume 7 | Issue 3 | e33420cellular levels and transport of GSSG in MRP1-silenced and
MRP1 overexpressed RPE cells. As expected, cellular levels of
GSH and GSSG significantly increased in MRP1-silenced RPE
cells. However, the increased GSSG did not cause any adverse
cytotoxicity since the expression of GR, the enzyme that converts
GSSG to GSH, showed a significant increase in MRP1-silenced
cells. Further, in control and MRP1 silenced RPE cells exposed to
H2O2, the GR activity was upregulated elevating cellular GSH
and thereby offering cellular protection (Fig. 7). Our observations
are consistent with models of vascular abnormalities and
hypertension in which MRP1 KO caused an increase in cellular
GSH and GSSG levels while the increased activity of GR
maintained the redox and protected cells from toxicity [14].
In summary, the present study describes the protective role of a-
crystallin and interelation between GSH and MRP1 in RPE. RPE
cells overexpressing a-crystallin are highly resistant to cell death
due to higher intracellular GSH levels and the redox status is
maintained by the efflux protein MRP1. Our results also show a
compensatory upregulation of GR with H2O2 treatment as in
human aortic endothelial cells [43]. On the other hand, MRP1-
overexpressing cells exposed to oxidative stress are susceptible to
apoptosis from decreased GSH levels caused by increased GSH
efflux. Taken together, our results demonstrate a direct interaction
among a-crystallin, GSH, and MRP1 in RPE cells and provide
evidence that MRP1 regulates GSH homeostasis by different ways
during oxidative stress. Enhancing the cellular defenses that
protect the retina and RPE against oxidative stress has been a
therapeutic objective aimed at reducing the progression of AMD.
The evidence linking the protective role of a-crystallin and GSH
and characterization of a transporter for GSH release offers new
avenues for the use of these proteins in the therapy of ocular
pathology.
Figure 8. GSH efflux in MRP1 overexpressing ARPE-19 cells. (A) Real-time PCR was performed from RNA extracted from control (parental
cells), vector transfected cells and cells transfected with human MRP1. MRP1 mRNA levels were normalized to GAPDH and data are presented as
relative fold change over control cells. (B) Immunoblot analysis for MRP1 protein expression. A significant 2.5 fold increase in MRP1 was found. (C)
MRP1 overexpressing cells release significantly higher quantities of GSH when compared to control cells. Oxidative stress (150 mMH 2O2 for 5 h)
further increased GSH release from control as well as from MRP1 overexpressing cells. (D) LDH release was not significantly altered in cells challenged
with H2O2 for 5 h in both control and in MRP1 overexpressing cells. However, LDH release showed a progressive increase when H2O2 exposure was
extended to 24 h and 36 h (n=9). (E) A time dependent activation of caspase 3 expression was found with H2O2 treatment and this increase was
maximal at 36 h. Cellular GSH (F) and GSSG (G) levels were significantly decreased in MRP1 overexpressing cells and oxidative stress with H2O2 further
decreased GSH levels. GSSG levels showed a significant increase in H2O2 treated vector control cells and were very low in MRP1 overexpressed cells in
the presence or absence of H2O2. (H) GSH efflux was higher in MRP1 overexpressed cells and oxidative stress further increased this efflux. * P,0.05,
** P,0.01.
doi:10.1371/journal.pone.0033420.g008
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Ethics statement
This study conforms to applicable regulatory guidelines at the
University of Southern California, principles of human research
subject protection in the Declaration of Helsinki and principles
of animal research in the Association for Research in Vision
and Ophthalmology Statement for the Use of Animals in
Ophthalmic and Vision Research. The Institutional Review
Board (IRB) of the University of Southern California approved
our use of human RPE cells under protocol #HS-947005
(continuing review approved June 7, 2011). Human fetal eyes
(16–18 week gestation) were obtained from Advanced Bioscience
Resources Inc. (ABR, Alameda, CA) and written informed consent
was obtained from all donors. The University of Southern
California Institutional Animal Care committee approved our
animal studies under protocol # 11135 (continuing review
approved January 26, 2011).
Cell Culture
ARPE-19 cells were obtained from American Type Culture
Collection (ATCC, Manassas, VA). The protocol for generation of
long-term polarized human fetal primary RPE cultures has been
described in detail previously [49]. Human fetal eyes (16–18 week
gestation) were obtained from Advanced Bioscience Resources
Inc. (ABR, Alameda, CA). Isolation of RPE cells from a-crystallin
KO and WT mice was carried out as described earlier [23].
Construction of aA and aB-crystallin cDNAs
Full-length aA and aB-crystallin cDNAs were amplified from
human fetal lens and fetal RPE, respectively, and cloned into a
mammalian expression vector. Briefly, full-length a-crystallin
cDNA (aA and aB crystallin) were amplified using the primer
sequences (Table S1). The PCR products were digested with
EcoR1 and Zho1, and then ligated into pcDNA 3.1 mammalian
expression vector (Invitrogen, Carlsbad, USA) having a neomycin
resistance gene for selection. Sequences were confirmed by DNA
sequencing in the core facility of the Norris Cancer Center of the
University of Southern California.
Generation of stable cell lines
In order to ensure consistency in transfection studies, stable
transfections were performed in ARPE-19 cells. Cells were
transfected with the neomycin–resistant pcDNA vectors contain-
ing aAo raB crystallin inserts using FuGene 6 transfection reagent
(Roche, IN). Cells were allowed to recover in DMEM/HAM’s F12
with 10% FBS for 24 h and were sub-cultured in selection
medium containing 500 mg/ml G418 sulfate (Sigma, St. Louis,
MO). After 3 weeks, individual colonies were isolated, sub-
cultured, expanded and examined for expression of aA and aB
crystallin by immunoblot analysis with anti-aA and anti-aB
crystallin antibodies (Novus Biologicals, Littleton, CO; Enzo Life
Sciences, Farmingdale, NY).
MRP1 overexpression
Generation of the human MRP1 cDNA cloned into the pcDNA
3.1 vector has been described [50]. ARPE-19 cells were
transfected with the MRP1 pcDNA 3.1 vector and 48 h after
transfection, mRNA and protein was isolated. Expression of
MRP1 in the transfected cells was determined by real-time RT-
PCR and by immunoblot analysis using a mouse monoclonal
MRP1 antibody (Santa Cruz Biotech, Santa Cruz, CA). Cellular
toxicity was determined by LDH assay [25].
siRNA-mediated downregulation of MRP1 and aB
crystallin
ARPE-19 cells at 50–60% confluence were transfected with pre-
designed siRNA-MRP1, aB crystallin duplexes or scrambled
siRNA (Dharmacon, Lafayette, CO) using HiPerFect transfection
reagent (Qiagen, Valencia, CA). MRP1 mRNA and protein
expression were analyzed by real-time RT-PCR and immunoblot
analysis, respectively. aB crystallin protein expression was
determined by immunoblot analysis.
Detection of Apoptosis
aA and aB crystallin and empty vector clones grown on 4-well
chamber slides were starved overnight in 1% FBS-containing
medium and treated with 150 mMH 2O2 for an additional 24 h.
Cell death was assessed by Terminal deoxynucleotidyl transferase
dUTP nick end labeling (TUNEL) following the manufacturer’s
protocol (Roche, IN). TUNEL positive cells were counted and
quantified as described [21,26].
GSH and GSSG Analysis
Total cellular glutathione content in RPE/choroid complex and
neural retina was measured following the manufacturer’s protocol.
Mitochondria and cytosol were isolated using a Mitochondria/
Cytosol fractionation kit [23]. GSH and GSSG levels were
measured with a commercially available kit (Oxford Biomedical
Research, Oxford, MI). Total GSH levels were expressed either as
mmol/ml or nmol/mg total protein and were normalized to % of
controls.
GSH and GSSG Efflux from RPE cells
Control ARPE-19 cells as well as cells from a-crystallin
overexpressing, MRP1 overexpressing, and MRP1 siRNA treated
groups were treated with H2O2 in serum-free culture medium for
5, 24 or 36 h. After the experimental period, medium was
collected, centrifuged to remove dead cells and debris and GSH
and/or GSSG release was determined in the cell-free medium.
Total protein was isolated from the cells, quantified (Bio-Rad
Laboratories, Hercules, CA) and intracellular GSH or GSSG
content was measured. GSH release was expressed as nmol/ml per
unit time.
Immunoblot analysis
Cells were harvested after the specified treatment period and
protein was extracted from the cells or posterior eye cups [28].
Equal amounts of protein (25–75 mg) were resolved on 15 or 4–
15% Tris-HCl polyacrylamide gels as described previously [5,26].
Membranes were probed with rabbit polyclonal glutamate-
cysteine ligase, catalytic subunit (GCLC) (1:1000, Cayman, Ann
Arbor, MI), polyclonal glutamate-cysteine ligase, modifier subunit
(GCLM) anti-MRP1 (1:500), anti-glutathione reductase (1:500,
Santa Cruz Biotech, Santa Cruz, CA), anti-aA crystallin (1:1000),
anti-aB crystallin (1:1000, Enzo Life Sciences), overnight at 4uC.
After incubation with the corresponding secondary antibodies,
signals were detected using an enhanced chemiluminescence
system, membranes reprobed for GAPDH or b-actin.
Quantitative real-time PCR
Total RNA was isolated from ARPE-19 cells or mouse posterior
eye cups (neural retina, RPE and choroid) using TRIzol reagent
(Invitrogen, CA), and RNA quantified. Reverse transcription and
real-time PCR was performed as described earlier [26,32]. The
sequences of primers used are presented in Table S1. Relative
multiples of change in mRNA expression was determined by
MRP1-Mediated GSH Efflux in RPE Cells
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2DDCT. Results are reported as mean difference in
relative multiples of change in mRNA expression 6 SEM.
Immunofluorescence cell staining
Cells were grown on 4-well chamber slides or human fetal RPE
monolayers on transwell filters were processed [25,51]. After
incubation with primary antibody (anti-MRP1 1:50), slides were
incubated with fluorescein -conjugated secondary antibody
(Vector Lab, CA) and were examined using a laser scanning
confocal microscope (LSM510, Zeiss, NY).
Biotinylation
RPE cells (2610
6 per flask) at 90% confluence were used for
biotinylation as suggested by the manufacturer (Thermo Scientific,
Rockford, IL). Briefly, cells were incubated with 10 ml biotin
solution on a shaker for 30 min at 4uC and the cells were gently
scraped and collected by centrifugation. The cells were sonicated
and incubated on ice for 30 min with vortexing in between every
5 min. The samples were centrifuged and the supernatant was
added to the microcentrifuge spin column. The column was
subjected to low speed centrifugation, and finally 300 ml of sample
buffer was added to the column and incubated 1 hr at room
temperature. The membrane fraction was collected by centrifu-
gation and was subjected to immunoblot analysis.
Data Analysis
Data were analyzed with InStat (GraphPad Software, San
Diego, CA). ANOVA and Tukey post hoc test were used to assess
the differences between groups. P,0.05 was considered to be
statistically significant.
Supporting Information
Figure S1 Expression of redox family members in aA
crystallin KO and WT mice. Changes in redoxin mRNA (A)
and protein (B) in WT and aA crystallin KO retina. mRNA and
protein were extracted from the posterior eye cup. (A) Real-time
PCR was used to amplify the mRNA levels. Data are normalized
to L32 and presented as relative fold difference over control (WT).
(B) 25–50 mg total protein was loaded for Western blot analysis
and probed with rabbit Trx1, goat Trx2 and rabbit Grx1.
GAPDH was used as a loading control. All four redox proteins
showed a significant decrease in expression when compared to
corresponding age-matched wild type. Trx1- Thioredoxin 1,
Trx2- Thioredoxin 2, Grx1- Glutaredoxin 1, Grx2- Glutaredoxin
2. * P,0.05, ** P,0.01.
(TIF)
Figure S2 Expression of MRP family members in RPE
cells. A. RT-PCR showing the expression of isoforms of MRPs in
RPE cells. Agarose gel separation of the amplification products
showed cDNA fragments of the expected size for MRP1, MRP2,
MRP3, MRP4, MRP5, MRP6 and MRP7. See Suppl.Table 1 for
the primers used. B. Real time–PCR showing the relative
abundance of MRPs in RPE cells. Data presented are normalized
with GAPDH as housekeeping gene and MRP1 as 1. MRP1
showed the highest abundance, followed by MRP5 and MRP7.
*P ,0.05, ** P,0.01.
(TIF)
Table S1 PCR primers utilized in this study.
(DOC)
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